Sustainability & Climate

The chicken chain is launching three meal-sized wraps and reviving a fan-favorite shake in a strategic bid for dominance in the competitive QSR market.

A limited 4/20 drop from jewelry giant GLD and THC beverage brand Tempter's signals a new era where luxury and cannabis culture are one and the same.

Tampax partners with WNBA stars to tackle the period taboo, marking a major shift in how brands engage with the booming women's sports market.

A landmark conference merges top organizations to accelerate research on retinal diseases, from gene editing to AI, offering new hope for millions worldwide.

The Irish retailer's massive new store in Herald Square signals a major battle for affordable fashion dominance in one of the world's top retail markets.

At a landmark Singapore summit, Asia's top firms were honored not just for profits, but for purpose, people, and planetary impact. Here's what it means.

A groundbreaking knee implant offers Hoosiers a new joint-preserving option, bridging the gap between conservative care and total knee replacement.

Former Oshkosh AeroTech director Eric Davis joins Mercury GSE to scale its service-first model, aiming to set a new standard for equipment uptime in North America.

With female founders still getting only 2% of VC funds, this summit bypasses talk for action, connecting 150 entrepreneurs with 150 investors.

A new alcohol-free, no-refrigeration blood pressure liquid aims to transform daily treatment for children, reflecting a key industry shift.

New Cufflink Nova™ AI promises to slash utility bills for schools and hospitals by turning data into decisions, with a core focus on data privacy.

Period care brand The Flex Co. launches a new 6-pack and national campaign, aiming to make menstrual discs less intimidating for a new generation.

Astellas and Pfizer's PADCEV-Keytruda combo, showing a 47% drop in recurrence risk, earns FDA Priority Review, offering new hope for bladder cancer patients.

WES raises its quarterly distribution by 2.2%, backed by record financials and a bullish outlook for the midstream energy sector's harvest phase.

Biogen consolidates worldwide rights for its promising immunology drug felzartamab, acquiring China rights from TJ Biopharma in a strategic $850M deal.

A Texas jury awarded a historic $1.6 billion to families of two workers, finding a "systemic failure of safety" and gross negligence by a chemical facility owner.

Guide's new ApexVision technology, launched at Hannover Messe, promises unprecedented thermal sensitivity, challenging industry leaders and transforming safety.

With a new 17,000 sq ft facility, an Idaho tech firm is scaling its revolutionary 3D printing to meet surging aerospace and defense composite demand.

A Shanghai-based firm's new approach could create cancer-fighting cells inside the body, slashing costs and wait times for CAR-T therapy.

A Swiss-Indian partnership aims to halt diseases like Alzheimer's and ALS by repairing damaged cell membranes, a groundbreaking approach to a global crisis.